Here are the DEF 14A proxy statements from Horizon Space Acquisition II Corp. Right (HSPTR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow HSPTR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HSPTR filings page.
Horizon Space Acquisition II Corp. is asking shareholders to approve amendments to its charter and trust agreement at a February 13, 2026 extraordinary meeting. These changes would let the SPAC extend its deadline to complete an initial business combination, including the proposed SL Bio merger, from February 18, 2026 up to February 18, 2027 through up to twelve one‑month extensions.
For each monthly extension, the sponsor or its designee would deposit the lesser of $50,000 or $0.033 per remaining public share into the trust account. Public shareholders may redeem some or all public shares in connection with the extension vote for cash equal to their pro rata portion of the trust, which was about $10.53 per share as of December 29, 2025, compared with a Nasdaq closing price of $10.55 that day. If the extension is not approved and no deal closes by the current deadline (or existing extensions), the company may redeem all public shares and liquidate, and the rights in the units would expire worthless.